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Abstract:  TRAIL is a promising candidate for cancer therapeutics that preferentially 
induces apoptosis in cancer cells. The combined treatment flavonoids with TRAIL might be 
promising as a chemoprevention and/or new therapy against malignant tumors.  We 
examined the cytotoxic effect of dietary flavonoids in combination with TRAIL on HeLa 
cells. It was found that treatment with noncytotoxic concentration of some flavonoids 
significantly sensititizes to TRAIL induced death in HeLa cells. Our study demonstrated 
that flavone, apigenin and genistein markedly augmented TRAIL mediated cytotoxicity 
against HeLa, whereas kaempferol and quercetin produced no effect.  
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1. Introduction 
Flavonoids are polyphenolic compounds found as integral components in the human diet. They are 
universally present as constituents of flowering plants, particularly of food plants. The high intake of 
foods and beverages rich in polyphenols, especially in flavonoids, has been associated with decreased 
risk of neoplasm. Dietary flavonoids inhibit the proliferation of various cancer cells and tumor growth 
in animal models [1–4]. Epidemiologic data suggested that flavonoids consumption may protect 
against cancer induction in several human tissues. Chemoprevention has the potential to be a major 
component of colon, lung, prostate and bladder cancer control [5,6]. Several of polyphenolic Int. J. Mol. Sci. 2008, 9  57  
 
 
compounds regulate the genes that are critical for the control of proliferation, cell cycle and apoptosis 
pathway in cancer cells [7]. Recently it has been reported that flavonoids sensitized in vitro cancer 
cells to apoptosis induced by anticancer agents, for example the tumor necrosis factor (TNF)-family 
members (death ligands) [8–19]. 
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for 
cancer therapeutics due to its ability to selectively induce apoptosis in malignant tumor cells with no 
toxicity against normal tissues. Soluble or expressed on lymphocytes T, macrophage and NK cells 
TRAIL play an important role in immune surveillance and defence mechanism against tumor cells. 
The mechanisms of cytotoxicity are TRAIL mediated induction of tumor cells death [20]. The 
cytotoxic effector functions of those immune cells are important for enabling the immune system to 
cope efficiently with malignancy. TRAIL induces apoptosis in various malignant tumor cells through 
its interaction with  the death-domain containing receptor TRAIL-R1 (death receptor 4 – DR4) and/or 
TRAIL-R2 (death receptor 5 – DR5) [21]. However, some tumor cells are resistant to   
TRAIL-mediated cytotoxicity. The decreased expression of death receptors TRAIL-R1 and TRAIL-R2 
or increased expression of antiapoptotic protein in cancer cells were involved in TRAIL-resistance 
[22]. The TRAIL-mediated cytotoxicity pathways may be a target of the dietary flavonoids in human 
tumor cells and the overcome of TRAIL-resistance by flavonoids may be one of the mechanisms 
responsible for their cancer-preventive effects [8-14]. 
Luteolin has been reported for the first time to overcome the resistance to TRAIL mediated 
apoptosis in HeLa cells [10]. Luteolin synergistically sensitizes TRAIL induced apoptosis in HeLa 
associated with up-regulation of death receptors TRAIL-R2 [11]. These findings suggest that the 
combined administration of luteolin and TRAIL may be a useful strategy for cancer therapy. 
In this study, we show that flavone, apigenin and genistein enhanced TRAIL-mediates cytotoxicity 
in human cervical HeLa cells, whereas kaempferol and quercetin produced no effect. We demonstrated 
for the first time activity of those flavonoids differing in chemical structure (presence of hydroxyl 
group in position 4’) on the same cell line. The results of performed experiments demonstrated 
activities of those dietary flavonoids in TRAIL-mediated cytotoxicity pathway in cancer cells and 
raised the possibility that combined effect of TRAIL and flavonoids can be used as a promising 
strategy for prevention or treatment of malignant tumors. 
2. Results and Discussion 
Recently it has been reported that flavonoids sensitized in vitro cancer cells to apoptosis induced by 
anticancer agents for example the members of the TNF family: TNFalpha, Fas or TRAIL [8-19]. 
Tumor necrosis factor superfamilly is a group of cytokines with important functions in immunity, 
inflammation, differentiation, control of cell proliferation, and apoptosis. These cytokines induce cell 
death through sequential recruitment by death receptors and rapid activation of a cascade of caspases 
[23,24]. 
In this study, we investigated the cytotoxic effect of recombinant human TRAIL at the 
concentrations of 25 – 200 ng/ml on human cervical cancer cells. HeLa cell line was relatively 
resistant to TRAIL mediated cytotoxicity at these concentrations. Flavonoids alone, were similar to 
TRAIL weakly induced cytotoxicity in HeLa cells. Structures of used flavonoids are shown in Table 1.  Int. J. Mol. Sci. 2008, 9  58  
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Pretreatment with dietary flavonoids sensitized HeLa cells to agents that specifically target death 
receptors (TRAIL, Fas, TNFalpha) [10,11,18]. 
Next, we tested the cytotoxic effects of dietary flavonoids: flavone, apigenin, kaempferol, quercetin 
and genistein in combination with TRAIL at the concentrations of 100 ng/ml on HeLa cell line. There 
was observed an additive cytotoxic effect on the three flavonoids (flavone, apigenin, genistein) in 
combination with TRAIL. The two other, kaempferol and quercetin had no effect on TRAIL-mediated 
cytotoxicity. Inhibitory effects of the flavonoids in combination with TRAIL on HeLa cell line are 
shown in Table 2. 
Table 2. The cytotoxic effects of flavonoids in combination with TRAIL on HeLa cell line 
measured by MTT method. 
Compound IC50 (µM)
a
1  Flavone 49.69+1.08 
2  Apigenin 43.05+0.86 
3  Kaempferol nd
b
4  Quercetin nd 
5  Genistein 49.64+2.43 
a Data shown represent the mean + SD of three independent experiments; 
b nd (not  determined) – IC50 > 50µM /had not effect 
 
Flavone, apigenin, genistein alone exhibited very weak antitumor activity with IC50 values > 50 µM 
(cytotoxicity at concentration 50 µM was near zero), but in combination with TRAIL the IC50 values 
increased to  43.05 – 49.69 µM. 
The necrotic cell death percentage of cancer cells incubated with flavonoids in combination with or 
without TRAIL, examined by lactate dehydrohenase (LDH) leakage was around 0%. Int. J. Mol. Sci. 2008, 9  59  
 
 
Figure 1. The apoptotic effecs of flavonoids and flavonoids with TRAIL on HeLa cells. 
Concentration of flavonoids - 50µM. The results of studies are expressed as mean   









































Flavonoids or with TRAIL combination increase the percentage of apoptotic cells (Figure 1). The 
most activity is marked for apigenin and genistein. Addition of TRAIL to kaempferol or quercetin did 
not change of the percentage of apoptotic cells. Both kaempferol and quercetin have hydroxyl group in 
position 3. 
Epidemiological and preclinical evidence suggests that polyphenolic phytochemicals posses cancer 
chemopreventive properties. The use of these agents for cancer prevention is driven by epidemiology 
supporting the idea that regional diets and consumption of specific dietary component such as soya 
isoflavones are associated with lower risk for cancer [5,6]. 
Flavone, apigenin, genistein restored TRAIL sensitivity in TRAIL-resistant HeLa cells. Similar 
study with apigenin showed sinergistically augments TRAIL – induced apoptosis in human malignant 
tumor cells: Jurkat cells, prostate cancer DU-145, colon cancer DLD-1. Apigenin partially prevented 
the degradation of DR5 protein and significantly increased DR5 protein in the membrane fraction, very 
slightly increased DR5 mRNA and did not enhanced promotor activity [14]. 
 Kaempferol and quercetin in combination with TRAIL demonstrated rather weak inhibitory 
activity against HeLa cells. 
The previous study indicate the strong ROS (reactive oxygen species) accumulation upon TRAIL 
induction, with activation of caspases, followed by cells death and oxidative stress mediates   
TRAIL-induced cytotoxicity in HeLa cells [25].  
The capability of flavonoids to overcome the resistance to TRAIL induced cytotoxicity in cancer 
cells might be predicted on the basis of their chemical composition and structure. Our early Int. J. Mol. Sci. 2008, 9  60  
 
 
investigation showed stimulation of luminol oxidation by hydrogen peroxide with horseradish 
peroxidase by apigenin. Kaempferol and quercetin strongly inhibited this reaction. It was dependent on 
their chemical structures. The presence of hydroxyl group in position 4’ (apigenin) stimulated the 
reaction but hydroxyl group in position 3 and hydroxyl group in position 4’ (kaempferol) or two 
hydroxyl groups in phenyl ring and in position 3 (quercetin ) inhibited this reaction. We hypothesize 
that observed  higher activity of apigenin  than quercetin and kaempferol  may be partially dependent 
on their ability to reaction with ROS [26]. To show this dependence comparative analysis of the effects 
of more flavonoids in combination with TRAIL in cancer cells is required. 
Our results suggested that the sensitization of TRAIL-mediated apoptosis may be a target of the 
dietary flavonoids in tumor cells. Chemopreventive effect of those flavonoids is based on several 
mechanisms [3,6,9-21]. Induction of ROS by some of them, for example apigenin may play a role as 
an upstream mediator of caspases [27,28]. 
The numerous studies confirm a substantial role of endogenously expressed TRAIL as the effector 
molecule in immunosurveillance that eliminates developing and metastatic tumors [21,22]. However, 
not all tumor cells are susceptible to TRAIL. It is therefore important to overcome by flawonoids this 
resistance for the clinical use of TRAIL in chemoprevention and/or cancer therapy. Three tested 
flavonoids: flavone, apigenin and genistein similar to luteolin [10] markedly augmented the 
cytotoxicity of TRAIL. Our study confirmed that combined treatment with those dietary flavonoids 
and TRAIL exhibit high inhibitory activity against cancer cells. 
The TRAIL-mediated apoptosis pathways in cancer cells may be one of the targets of anticancer 
function of flavonoids, and thus provide the molecular basis for the development of dietary flavonoids 
as a novel chemopreventive agents for tumor malignancy [7-10,14]. 
3. Conclusions 
Dietary flavonoids can help overcome the resistance to TRAIL and markedly induce cytotoxicity 
together with TRAIL in human cervical cancer HeLa cells. These results suggest that flavone, apigenin 
and genistein may be promising agents for cancer chemoprevention and therapy in combination with 
TRAIL. 
4. Experimental Section 
4.1. General 
Flavone, apigenin, kaempferol, quercetin, genistein were obtained from Carl Roth GmbH 
(Karsruhe, Germany) and Sigma Chemical Company (St. Louis, MO). The reagents were dissolved in 
DMSO to a final concentration of 0.01% in media. Soluble recombinant human TRAIL/Apo2L 
(rhsTRAIL) was purchased from PeproTech Inc. New Jersey, Rocky Hill. 
4.2. Cell culture 
HeLa cervical cancer cell line (DSMZ - Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH - German Collection of Microorganisms and Cell Cultures, Braunschweig, 
Germany) was cultured as monolayers and maintained in RPMI 1640 (PAA – The cell culture Int. J. Mol. Sci. 2008, 9  61  
 
 
company, Germany through Immuniq, Poland) containing 10% fetal bovine serum (PAA – The cell 
culture company, Germany through Immuniq, Poland), 100 U/ml penicillin and 100 µg/ml 
streptomycin (PAA – The cell culture company, Germany through Immuniq, Poland) in a humidified 
atmosphere with 5% CO2 at 37
o C.  
4.3. Cytotoxicity assay 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay 
For the experiments the cells were seeded onto 96-well microtiter plates at a density of 1 x 10
4 cells 
per well and allowed to adhere for 24 h. After this time the culture medium was removed and HeLa 
cells were incubated with rhsTRAIL at the concentrations of 100 ng/ml for 18 hours with or without 
flavonoids. The tested polyphenolic compounds were added over a concentration range of 10 – 50 µM. 
Working dilutions were freshly prepared on the day of testing. After 18 hours of incubation the cell 
growth rate was evaluated by MTT assays (Sigma Chemical Company, St. Louis, MO) [29]. The 
spectrophotometric absorbance of each well was measured by microculture plate reader with the test 
wavelength of 550 nm. The percent cytotoxicity was calculated by the formula, percent cytotoxicity = 
(1- (absorbance of experimental wells/absorbance of control wells)) x 100. 
The results are expressed as IC50, which is the concentration necessary for 50% inhibition. The IC50 
values for the combination of each compound with TRAIL are calculated from dose response curves 
using linear regression analysis by fitting the test concentrations that give percentage of inhibition 
values above and below the reference value (50%). 
4.4. LDH (lactate dehydrogenase) release assay 
LDH is a stable cytosolic enzyme that is released upon membrane damage. LDH activity was 
measured using a commercial cytotoxicity assay kit (Roche Diagnostics GmbH, Mannheim, 
Germany), in which released LDH in culture supernatants is measured with a coupled enzymatic assay, 
resulting in conversion of a tetrazolium salt into red formazan product. The cells were treated with 
various concentrations of flavonoids and/or rhsTRAIL for indicated period of time. The sample 
solution (supernatant) was removed and LDH released from cells was measured in culture medium 
[30]. Maximal release was obtained after treating control cells with 1% Triton X-100 (Sigma Chemical 
Company, St. Louis, MO) for 10 minutes at room temperature. The necrotic percentage was expressed 
using the formula, (sample value/maximal release) x 100%.  
4.5. Detection of apoptosis 
Apoptotic cells were quantified by microscopic method using Apoptotic & Necrotic & Healthy 
Cells Quantification Kit from Biotium, Inc. (Hayward, CA, USA) according to the manufacturer’s 
instruction. HeLa cells were washed with PBS and were detached from cell culture wells by trypsin. 
Next the cells were centrifuged to discard supernatant, washed with PBS and resuspended in Binding 
Buffer (100 µl/sample). To each tube were added 5 µl of FITC-Annexin V, 5 µl of Ethidium 
Homodimer III and 5 µl of Hoechst 33342 solutions. The samples were incubated at room temperature 
for 15 minutes in the dark. After staining the cells were washed with Binding Buffer and placed on a Int. J. Mol. Sci. 2008, 9  62  
 
 
glass slide and covered with a glass coverslip. The stained cells were observed under a fluorescence 
inverted microscope IX51 (Olympus, Tokyo, Japan) using filter set for FITC, TRITC and DAPI. The 
healthy cells emitted blue (stained by Hoechst), apoptotic cells emitted green and blue (stained by 
FITC-Annexin V and Hoechst) and necrotic cells emitted red and blue fluorescence (stained with 
Ethidium Homodimer and Hoechst). Cells stained with triple colors blue, red and green were dead 
cells progressing from apoptotic cell population. The cells were counted and apoptotic cells were 
expressed as percentage of total cells. 
The microscopic studies were performed at 50 µM concentration of flavonoids with or without 
TRAIL. 
4.6. Statistical analysis 
Each test point was measured in quadruplicate in three individual experiments. The results are 
expressed as IC50, a concentration necessary for 50% of inhibition. Each result is a mean value of IC50 
+ SD from three separate experiments. The IC50 values for each flavonoid were calculated from dose 
response curves using linear regression analysis by fitting the test concentrations that gave percentage 
of inhibition values above and below the reference value (50%) using PHARM/PCS – version 4 
Pharmacologic Calculation System based on  “Manual of paharmacologic calculation with computer 
programs”, 2
nd edition by R.J. Tallarida and R.B. Murray, Springer Verlag, New York, 1986. 
The results of microscopic studies are expressed as mean values + SD from three separate 
experiments. The data was analyzed using Student’s t test. Differences were considered to be 
statistically significant from the controls at P < 0.05. 
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